Alkem Laboratories

Alkem launches inhalation device – Innohaler for Asthma and COPD patients

Read more

Alkem Laboratories to launch technology for Diabetic Foot Ulcer management in India

Read more

Alkem Laboratories launches lung care division

Read more

Alkem Laboratories launches Ibuprofen, Famotidine tablets in US

Read more

Alkem Laboratories says US FDA inspection at Taloja facility ends with ‘zero’ observations

Read more

Alkem’s St Louis facility gets two observations from US FDA

Read more

Alkem launches Perampil (Perampanel Tablets)

Read more

NPPA fixes retail prices of 30 formulations, rejects four applications

Read more

Alkem Labs gets EIR from US FDA for Baddi facility

Read more

Alkem Labs Q3 net profit up 90 per cent to Rs 390 cr

Read more